Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Cancer Research
|
July 18, 2012
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set
William C Reinhold, Margot Sunshine, Hongfang Liu, et al.
Plos One
|
February 1, 2012
Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines
Barry R Zeeberg, William Reinhold, René Snajder, et al.
Human Genetics
|
September 13, 2014
Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer
William C Reinhold, Sudhir Varma, Vinodh N Rajapakse, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities
Hongfang Liu, Petula D'Andrade, Stephanie Fulmer-Smentek, et al.
Cancer Research
|
June 22, 2013
Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p
Stéphanie Solier, Michael C Ryan, Scott E Martin, et al.
Molecular Cancer Therapeutics
|
March 1, 2006
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex
Christophe Marchand, Smitha Antony, Kurt W Kohn, et al.
Cancer Research
|
September 7, 2010
Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors
Stéphanie Solier, Jennifer Barb, Barry R Zeeberg, et al.
Antimicrobial Agents and Chemotherapy
|
August 17, 2002
Importance of the fourth alpha-helix within the CAP homology domain of type II topoisomerase for DNA cleavage site recognition and quinolone action
Dirk Strumberg, John L Nitiss, Jiaowang Dong, et al.
Cancer Research
|
June 5, 2003
Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study
Sayed S Daoud, Peter J Munson, William Reinhold, et al.
Cancer Research
|
March 26, 2002
Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects
Yi Zhou, Fuad G Gwadry, William C Reinhold, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Cancer Research
|
July 18, 2012
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set
William C Reinhold, Margot Sunshine, Hongfang Liu, et al.
Plos One
|
February 1, 2012
Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines
Barry R Zeeberg, William Reinhold, René Snajder, et al.
Human Genetics
|
September 13, 2014
Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer
William C Reinhold, Sudhir Varma, Vinodh N Rajapakse, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities
Hongfang Liu, Petula D'Andrade, Stephanie Fulmer-Smentek, et al.
Cancer Research
|
June 22, 2013
Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p
Stéphanie Solier, Michael C Ryan, Scott E Martin, et al.
Molecular Cancer Therapeutics
|
March 1, 2006
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex
Christophe Marchand, Smitha Antony, Kurt W Kohn, et al.
Cancer Research
|
September 7, 2010
Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors
Stéphanie Solier, Jennifer Barb, Barry R Zeeberg, et al.
Antimicrobial Agents and Chemotherapy
|
August 17, 2002
Importance of the fourth alpha-helix within the CAP homology domain of type II topoisomerase for DNA cleavage site recognition and quinolone action
Dirk Strumberg, John L Nitiss, Jiaowang Dong, et al.
Cancer Research
|
June 5, 2003
Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study
Sayed S Daoud, Peter J Munson, William Reinhold, et al.
Cancer Research
|
March 26, 2002
Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects
Yi Zhou, Fuad G Gwadry, William C Reinhold, et al.
Page
of 5